228 related articles for article (PubMed ID: 1541421)
1. Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2.
Manzano L; Alvarez-Mon M; Abreu L; Antonio Vargas J; de la Morena E; Corugedo F; Duràntez A
Gut; 1992 Feb; 33(2):246-51. PubMed ID: 1541421
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy is associated with a reduction in the pattern of the cytotoxic activity displayed by lymphokine-activated killer cells.
Salméron OJ; Vaquer S; Salmerón I; Moltó L; Lapeña P; Manzano L; de las Heros JI; Alvarez-Mon M
Am J Reprod Immunol; 1991 Dec; 26(4):150-5. PubMed ID: 1840730
[TBL] [Abstract][Full Text] [Related]
3. Impaired activity of natural killer cells in patients with acute brucellosis.
Salmerón I; Rodríguez-Zapata M; Salmerón O; Manzano L; Vaquer S; Alvarez-Mon M
Clin Infect Dis; 1992 Nov; 15(5):764-70. PubMed ID: 1445973
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
Chang WC; Hsiao MH; Pattengale PK
Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.
Carballido JA; Moltó LM; Manzano L; Olivier C; Salmerón OJ; Alvarez de Mon M
Cancer; 1993 Sep; 72(5):1743-8. PubMed ID: 8348503
[TBL] [Abstract][Full Text] [Related]
6. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
[TBL] [Abstract][Full Text] [Related]
7. Diminished natural killer activity in pregnancy: modulation by interleukin 2 and interferon gamma.
Vaquer S; de la Hera A; Jordá J; Martínez C; Escudero M; Alvarez-Mon M
Scand J Immunol; 1987 Dec; 26(6):691-8. PubMed ID: 3122313
[TBL] [Abstract][Full Text] [Related]
8. Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection.
Corado J; Toro F; Rivera H; Bianco NE; Deibis L; De Sanctis JB
Clin Exp Immunol; 1997 Sep; 109(3):451-7. PubMed ID: 9328121
[TBL] [Abstract][Full Text] [Related]
9. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
10. Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans.
Scaringi L; Cornacchione P; Rosati E; Boccanera M; Cassone A; Bistoni F; Marconi P
Cell Immunol; 1990 Sep; 129(2):271-87. PubMed ID: 2166624
[TBL] [Abstract][Full Text] [Related]
11. Distal procto-colitis, natural cytotoxicity, and essential fatty acids.
Almallah YZ; Richardson S; O'Hanrahan T; Mowat NA; Brunt PW; Sinclair TS; Ewen S; Heys SD; Eremin O
Am J Gastroenterol; 1998 May; 93(5):804-9. PubMed ID: 9625132
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.
Shau H; Isacescu V; Ibayashi Y; Tokuda Y; Golub SH; Fahey JL; Sarna GP
J Biol Response Mod; 1990 Feb; 9(1):71-80. PubMed ID: 2319261
[TBL] [Abstract][Full Text] [Related]
13. In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.
Aparició-Pagés MN; Verspaget HW; Peña AS; Weterman IT; de Bruin PA; Mieremet-Ooms MA; van der Zon JM; van Tol EA; Lamers CB
J Clin Lab Immunol; 1989 Jul; 29(3):119-24. PubMed ID: 2517428
[TBL] [Abstract][Full Text] [Related]
14. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy.
Phillips JH; Gemlo BT; Myers WW; Rayner AA; Lanier LL
J Clin Oncol; 1987 Dec; 5(12):1933-41. PubMed ID: 3500280
[TBL] [Abstract][Full Text] [Related]
16. The role of natural killer cells and lymphokine activated killer cells in the pathogenesis of hepatic injury in hepatitis A [corrected].
Baba M; Fukai K; Hasegawa H; Nakayabu M; Suzuki S
J Clin Lab Immunol; 1992; 38(1):1-14. PubMed ID: 1343344
[TBL] [Abstract][Full Text] [Related]
17. Intestinal lymphokine-activated killer cells in inflammatory bowel disease.
Hogan PG; Gibson PR; Hapel AJ; Doe WF
J Gastroenterol Hepatol; 1991; 6(5):455-60. PubMed ID: 1932665
[TBL] [Abstract][Full Text] [Related]
18. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
[TBL] [Abstract][Full Text] [Related]
20. Generation of lymphokine-activated killer cell activity from human thymocytes.
Ramsdell FJ; Golub SH
J Immunol; 1987 Sep; 139(5):1446-53. PubMed ID: 2442246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
